Morningside Venture Investments Ltd - 02 Feb 2022 Form 3 Insider Report for GreenLight Biosciences Holdings, PBC

Role
10%+ Owner
Signature
/s/ Frances Anne Elizabeth Richards, for Morningside Venture Investments Limited
Issuer symbol
N/A
Transactions as of
02 Feb 2022
Net transactions value
$0
Form type
3
Filing time
17 Mar 2022, 17:33:15 UTC
Previous filing
17 Mar 2022
Next filing
15 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GRNA Class A Common Stock 02 Feb 2022 Common Stock 12,857,931 Direct F1, F2
holding GRNA Class A Common Stock 02 Feb 2022 Common Stock 1,000,000 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares of Class A common stock automatically convert into the same number of shares of the Issuer's Common Stock without payment or further consideration in connection with the closing of the Issuer's business combination transaction. The Class A Common Stock has no expiration date.
F2 Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho are the directors of Morningside and share voting and dispositive power with respect to the securities held by Morningside Venture Investments Limited ("Morningside") and MVIL, LLC ("MVIL LLC"), Morningside's wholly-owned subsidiary. Ms. Richard, Ms. Franklin, Mr. Edwards and Mr. Cheung each disclaim ownership of the securities owned by Morningside and MVIL LLC. Cheng Yee Wing Betty and Wong See Wai are the managers of MVIL and share voting and dispositive power with respect to the securities held by MVIL LLC. Ms. Cheng and Mr. Wong each disclaim ownership of the securities owned by MVIL LLC.
F3 Represent shares held by MVIL, LLC.

Remarks:

The Reporting Persons are jointly filing this Form 3 pursuant to Rule 16a-3(j) under the Securities Exchange Act of 1934.